SCHEMBL601699

SCHEMBL601699

OC1(C(F)(F)F)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3402868 0.93
Hydrochloric Acid SCHEMBL20241280 0.90
SCHEMBL91318 0.90 ALDH1A1 (0.33)
SCHEMBL15351328 0.86
SCHEMBL31470338 0.77
SCHEMBL25313 0.73
SCHEMBL13728352 0.73
SCHEMBL1593885 0.73 DRD2 (0.31)
SCHEMBL1377459 0.73
SCHEMBL26906347 0.73 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709481-A1 5,6-FUSED AND 6,6-FUSED BICYCLIC ALCOHOLS AND ETHERS AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP claimed
EP-4686368-A1 A MOLECULAR SOLAR THERMAL SYSTEM (MOST) FOR LONG-TERM STORAGE OF SOLAR ENERGY Johannes Gutenberg-Universität Mainz (DE) 2026-01-28 EP claimed
WO-2024233550-A1 5,6-FUSED AND 6,6-FUSED BICYCLIC ALCOHOLS AND ETHERS AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS AMGEN INC. (US) 2024-11-14 WO claimed
US-20260125398-A1 5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS AMGEN INC. (US) 2026-05-07 US disclosed
US-20260116885-A1 ION CHANNEL MODULATORS PRAXIS PREC MEDICINES INC (US) 2026-04-30 US disclosed
EP-4686368-A1 A MOLECULAR SOLAR THERMAL SYSTEM (MOST) FOR LONG-TERM STORAGE OF SOLAR ENERGY Johannes Gutenberg-Universität Mainz (DE) 2026-01-28 EP disclosed
US-20250387400-A1 TYK2 INHIBITORS BIOGEN MA INC (US) 2025-12-25 US disclosed
US-20250376475-A1 ION CHANNEL MODULATORS PRAXIS PREC MEDICINES INC (US) 2025-12-11 US disclosed
US-12344615-B2 Substituted pyridines as ion channel modulators PRAXIS PRECISION MEDICINES, INC. (US) 2025-07-01 US disclosed
EP-4562001-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS Nura Bio, Inc. (US) 2025-06-04 EP disclosed
US-20250145629-A1 ION CHANNEL MODULATORS PRAXIS PRECISION MEDICINES, INC. 2025-05-08 US disclosed
US-20120041009-A1 PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-16 US disclosed
WO-2010134478-A1 PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-25 WO disclosed
CN-101801925-A antiviral compounds GILEAD SCIENCES INC 2010-08-11 CN disclosed
EP-2162432-A2 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2010-03-17 EP disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 US disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 US disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 US disclosed
WO-2009005677-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2009-01-08 WO disclosed
WO-2009005677-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2009-01-08 WO disclosed